Polish
Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study
Overview of attention for article published in Investigational New Drugs, June 2013
Altmetric Badge
About this Attention Score
-
Above-average Attention Score compared to outputs of the same age (51st percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 24 Mendeley